Sheng Xia

3.4k total citations
98 papers, 2.3k citations indexed

About

Sheng Xia is a scholar working on Immunology, Molecular Biology and Oncology. According to data from OpenAlex, Sheng Xia has authored 98 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 41 papers in Immunology, 31 papers in Molecular Biology and 21 papers in Oncology. Recurrent topics in Sheng Xia's work include Immune Cell Function and Interaction (21 papers), T-cell and B-cell Immunology (11 papers) and Neonatal Respiratory Health Research (10 papers). Sheng Xia is often cited by papers focused on Immune Cell Function and Interaction (21 papers), T-cell and B-cell Immunology (11 papers) and Neonatal Respiratory Health Research (10 papers). Sheng Xia collaborates with scholars based in China, United States and Sweden. Sheng Xia's co-authors include Ling Qi, Qixiang Shao, Zhenhong Guo, Xiongfei Xu, Xuetao Cao, Yewei Ji, Rong Li, Shengyi Sun, Xiaogang Li and Darren P. Wallace and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Angewandte Chemie International Edition.

In The Last Decade

Sheng Xia

93 papers receiving 2.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sheng Xia China 27 992 738 350 319 263 98 2.3k
Josep M. Aran Spain 24 1.0k 1.0× 473 0.6× 157 0.4× 292 0.9× 245 0.9× 69 2.2k
Akula Bala Pramod United States 16 1.2k 1.2× 1.3k 1.8× 255 0.7× 301 0.9× 151 0.6× 29 2.7k
Yingxin Zhao United States 34 1.9k 1.9× 470 0.6× 303 0.9× 353 1.1× 148 0.6× 86 3.0k
Aiping Bai United States 37 1.8k 1.8× 807 1.1× 411 1.2× 330 1.0× 397 1.5× 73 3.2k
Saquib A. Lakhani United States 16 1.8k 1.8× 982 1.3× 638 1.8× 334 1.0× 212 0.8× 52 3.1k
Liyun Zhang China 26 911 0.9× 485 0.7× 150 0.4× 177 0.6× 130 0.5× 119 2.2k
Xiaoyi Yang China 29 1.2k 1.2× 341 0.5× 265 0.8× 501 1.6× 230 0.9× 99 2.6k
Keunwook Lee South Korea 29 1.2k 1.2× 1.0k 1.4× 166 0.5× 396 1.2× 108 0.4× 84 2.5k
Koen Vandenbroeck Spain 30 856 0.9× 1.2k 1.6× 286 0.8× 462 1.4× 235 0.9× 96 2.9k
Xinyu Gu China 28 1.4k 1.4× 369 0.5× 229 0.7× 422 1.3× 96 0.4× 99 2.6k

Countries citing papers authored by Sheng Xia

Since Specialization
Citations

This map shows the geographic impact of Sheng Xia's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sheng Xia with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sheng Xia more than expected).

Fields of papers citing papers by Sheng Xia

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sheng Xia. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sheng Xia. The network helps show where Sheng Xia may publish in the future.

Co-authorship network of co-authors of Sheng Xia

This figure shows the co-authorship network connecting the top 25 collaborators of Sheng Xia. A scholar is included among the top collaborators of Sheng Xia based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sheng Xia. Sheng Xia is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhu, Xiaofei, Xiaolan Yin, Wenyu Liu, et al.. (2025). Stereotactic body radiation therapy plus adoptive vNKT cell therapy for pancreatic cancer: protocol of a phase II trial. Immunotherapy. 17(10). 1–8.
2.
3.
Ke, Xingrao, Sheng Xia, Wei Yu, et al.. (2024). Delta like 4 regulates cerebrovascular development and endothelial integrity via DLL4‐NOTCH‐CLDN5 pathway and is vulnerable to neonatal hyperoxia. The Journal of Physiology. 602(10). 2265–2285. 3 indexed citations
4.
Ye, Fei, Xiao Yuan, Yali Ma, et al.. (2024). EGFR-TKIs Combined with Allogeneic CD8+ NKT Cell Immunotherapy to Treat Patients with Advanced EGFR-Mutated Lung Cancer. Technology in Cancer Research & Treatment. 23. 2234015086–2234015086. 1 indexed citations
5.
Chen, Junjie, Shu‐Yi Yin, Sheng Xia, et al.. (2024). A Grading System of Microvascular Invasion for Patients with Hepatocellular Carcinoma Undergoing Liver Resection with Curative Intent: A Multicenter Study. Journal of Hepatocellular Carcinoma. Volume 11. 191–206. 8 indexed citations
6.
Xia, Sheng, et al.. (2024). Hyperbaric Oxygen Therapy Improves Motor Symptoms, Sleep, and Cognitive Dysfunctions in Parkinson’s Disease. Dementia and Geriatric Cognitive Disorders. 54(3). 187–200. 1 indexed citations
7.
Guo, Zhenhong, et al.. (2024). NK-like CD8 T cell: one potential evolutionary continuum between adaptive memory and innate immunity. Clinical & Experimental Immunology. 217(2). 136–150. 7 indexed citations
8.
Zhou, Chenhao, Jialei Weng, Chunxiao Liu, et al.. (2023). Disruption of SLFN11 Deficiency–Induced CCL2 Signaling and Macrophage M2 Polarization Potentiates Anti–PD-1 Therapy Efficacy in Hepatocellular Carcinoma. Gastroenterology. 164(7). 1261–1278. 76 indexed citations
9.
Menden, Heather, Sherry M. Mabry, Aparna Venkatraman, et al.. (2023). The SARS-CoV-2 E protein induces Toll-like receptor 2-mediated neonatal lung injury in a model of COVID-19 viremia that is rescued by the glucocorticoid ciclesonide. American Journal of Physiology-Lung Cellular and Molecular Physiology. 324(5). L722–L736. 5 indexed citations
10.
Yu, Wei, Heather Menden, Sheng Xia, et al.. (2023). IRF7 and UNC93B1 variants in an infant with recurrent herpes simplex virus infection. Journal of Clinical Investigation. 133(11). 12 indexed citations
11.
Xia, Sheng, Heather Menden, Sherry M. Mabry, & Venkatesh Sampath. (2023). HDAC6 and ERK/ADAM17 Regulate VEGF-Induced NOTCH Signaling in Lung Endothelial Cells. Cells. 12(18). 2231–2231. 6 indexed citations
12.
13.
Wu, Haojie, Xiaohan Li, Chen Zhou, et al.. (2021). Circulating mature dendritic cells homing to the thymus promote thymic epithelial cells involution via the Jagged1/Notch3 axis. Cell Death Discovery. 7(1). 225–225. 5 indexed citations
14.
15.
Fang, Zhengzou, Yusheng Niu, Yan Wu, et al.. (2017). Fabrication of HA/PEI-functionalized carbon dots for tumor targeting, intracellular imaging and gene delivery. RSC Advances. 7(6). 3369–3375. 83 indexed citations
16.
Yu, Qiang, Jie Xu, Chong Yan, et al.. (2017). Butyrate and retinoic acid imprint mucosal-like dendritic cell development synergistically from bone marrow cells. Clinical & Experimental Immunology. 189(3). 290–297. 15 indexed citations
17.
Menden, Heather, et al.. (2016). Nicotinamide Adenine Dinucleotide Phosphate Oxidase 2 Regulates LPS-Induced Inflammation and Alveolar Remodeling in the Developing Lung. American Journal of Respiratory Cell and Molecular Biology. 55(6). 767–778. 32 indexed citations
18.
Liu, Xia, Qianqian Zhao, Xin Peng, et al.. (2014). PTD-mediated intracellular delivery of mutant NFAT minimum DNA binding domain inhibited the proliferation of T cells. International Immunopharmacology. 19(1). 110–118. 5 indexed citations
19.
Tong, Jia, Shengjun Wang, Zhaoliang Su, et al.. (2012). Corynebacterium pyruviciproducens, as an immune modulator, can promote the activity of macrophages and up-regulate antibody response to particulate antigen. Experimental Biology and Medicine. 237(11). 1322–1330. 11 indexed citations
20.
Zeng, Xin, Yong Lin, Sheng Xia, et al.. (2010). Combination of taurine with silybin meglumine in treatment of patients with non-alcohlic steatohepatitis. Zhonghua xiaohua zazhi. 30(7). 441–443. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Josep M. Aran Breakdown of academic impact, for papers by Akula Bala Pramod Breakdown of academic impact, for papers by Yingxin Zhao Breakdown of academic impact, for papers by Aiping Bai Breakdown of academic impact, for papers by Saquib A. Lakhani Breakdown of academic impact, for papers by Liyun Zhang Breakdown of academic impact, for papers by Xiaoyi Yang Breakdown of academic impact, for papers by Keunwook Lee Breakdown of academic impact, for papers by Koen Vandenbroeck Breakdown of academic impact, for papers by Xinyu Gu
Rankless by CCL
2026